Tech Company M&A Transactions
Vividion Therapeutics Acquisition
Vividion Therapeutics was bought by Bayer AG. The transaction occurred on 8/5/2021. Bayer AG said the transaction price was $2 billion.
Transaction Overview
Company Name
Acquired By
Announced On
8/5/2021
Transaction Type
M&A
Amount
$2,000,000,000
M&A Terms
Bayer is paying $1.5 billion upfront and up to $500 million in success-based milestone payments.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
5820 Nancy Ridge Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Vividion Therapeutics is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide ligand and target discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Hatfield
Chief Financial Officer
Patty Allen
Chief Scientific Officer
Robert Abraham
Browse more venture capital transactions:
Prev: 8/5/2021: Connections Health Solutions venture capital transaction
Next: 8/5/2021: Yellow.ai venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs